Copyright
©The Author(s) 2021.
World J Diabetes. Jul 15, 2021; 12(7): 954-974
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.954
Published online Jul 15, 2021. doi: 10.4239/wjd.v12.i7.954
Ref. | Dosage | Ejaculation after | n | No. of successes | Ejaculate volume (ml) | Sperm count (106/m) | Sperm motility (%) |
Brompheniramine | |||||||
Andaloro et al[152] | 16 mg/d p.o. | 12 h | 1 | 1 | Unclear | Unclear | Unclear |
Budd[153] | 16 mg/d p.o. | 3 d | 1 | 1 | Unclear | Unclear | Unclear |
Chlorpheniramine + phenylpropanalamine | |||||||
Stewart et al[154] | 50 mg/d p.o. | Unclear | 1 | 1 | 4.5 | Normal | Normal |
Ephedrine | |||||||
Gilja et al[155] | 50 mg/d p.o. | 4 wk | 17 | 3 | Unclear | Unclear | Unclear |
Arafa et al[156] | 120 mg twice/d | 14 d | 23 | 11 | Unclear | Unclear | Unclear |
Shoshany et al[157] | 60 mg/6 h the day before test + 2 doses on test day | At the test | 6 | 4 | 1.5 | Unclear | 17.8 |
Imipramine | |||||||
Brooks et al[158] | 75 mg/d p.o. | 1 wk | 2 | 2 | 3 | 1.72 | 33 |
Okada et al[159] | 25-150 mg/d | Unclear | 7 | 3 | Unclear | Unclear | Unclear |
Gilja et al[155] | 75 mg/d p.o. | 4 wk | 14 | 2 | Unclear | Unclear | Unclear |
Eppel et al[160] | 50 mg/d p.o. | 5 d | 3 | 3 | 8 | 20 | 50 |
Arafa et al[156] | 50 mg/d p.o | 14 d | 23 | 10 | Unclear | Unclear | Unclear |
Imramine + pseudoepherine | |||||||
Arafa et al[156] | 50 + 120 mg/d | 14 d | 23 | 16 | Unclear | Unclear | Unclear |
Amoxapine | |||||||
Hibi et al[161] | 50 mg/d | 1 mo | 1 | 1 | 0.2 | 213 | 53 |
- Citation: Mostafa T, Abdel-Hamid IA. Ejaculatory dysfunction in men with diabetes mellitus. World J Diabetes 2021; 12(7): 954-974
- URL: https://www.wjgnet.com/1948-9358/full/v12/i7/954.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i7.954